(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much as 43% last year compared to previous years, following the widespread ...

ATLANTA -- Maternal respiratory syncytial virus (RSV) vaccination during pregnancy and infant RSV immunization -- either alone or combined -- appeared to be safe and effective at boosting neutralizing ...

RSV prevention products led to a significant reduction in hospitalization rates for infants aged 0 to 7 months during the 2024-2025 season. The maternal RSV vaccine and nirsevimab were key ...

"This study is crucial, as it provides high-quality evidence supporting the efficacy of maternal RSV vaccination." — Emily Phijffer, MD, Wilhelmina Children’s Hospital, at University Medical Center ...

It’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ages, especially in the late ...

During the first respiratory syncytial virus (RSV) season in France, passive infant immunisation with nirsevimab was associated with a lower risk for hospitalisation for RSV-related lower respiratory ...

An antibody treatment for respiratory syncytial virus (RSV) appears to be more effective at protecting infants from severe illness than vaccination during pregnancy. About 100,000 children worldwide ...

High-flow nasal cannula shows similar efficacy to CPAP in preventing BPD in preterm infants, with a significantly lower risk of nasal injury.

Coinfection with RSV and RV is common in hospitalized children, but the impact of order of infection on disease severity remains unclear, according to Emily Schultz, MPhil, a PhD candidate in ...

Respiratory syncytial virus (RSV) is a common virus that affects the nose, throat, and lungs. For most healthy adults and children, it causes only mild, cold-like symptoms and goes away on its own.